Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

06-1769 - USA v. Abbott Laboratories et al


Download Files

Metadata

Document in Context
06-1769 - USA v. Abbott Laboratories et al
March 30, 2012
PDF | More
MEMORANDUM OPINION AND ORDER: The Motions to Dismiss filed by 110 Boston Scientific Corporation and 112 Cordis Corporation and Johnson&Johnson are GRANTED, and the 115 Motion to Dismiss filed by Abbott Laboratories and Abbott Vascular Solutions, Inc. is GRANTED in part and DENIED in part. If Colquitt chooses to amend his pleadings, he may do so on or before 4/27/2012, by filing a clean and red-lined Fourth Amended Complaint. (Ordered by Judge Barbara M.G. Lynn on 3/30/2012) (skt)
January 7, 2016
PDF | More
Motion for Partial Summary Judgment [Docket Entry #440] are DENIED. (Ordered by Judge Barbara M.G. Lynn on 1/7/2016) (axm) Memorandum Opinion and Order: Relator's Motion to Strike [Docket Entry # 459] and Supplemental Motion to Strike [Docket Entry #495] are DENIED as moot. Defendants' Motion for Summary Judgment [Docket Entry #443] and Relator's
March 23, 2016
PDF | More
MEMORANDUM OPINION AND ORDER: This Memorandum Opinion and Order sets forth the grounds for the Court's 755 decision denying Relator's 740 Objection to Defendants' designation of Linda Dickes as their corporate representative for trial. Relator's Objection is OVERULED. Ms. Dickes will not be excluded under Federal Rule of Evidence 615. (Ordered by Judge Barbara M.G. Lynn on 3/23/2016) (sss)